# Give Legacy – FDA Inspection, Mar 10, 2026

Source: https://www.keypedia.com/records/fda_inspections/give-legacy/da2ded9d-d92b-4473-a5b2-dc2c5b1a3e39
Source feed: FDA_Inspections

> FDA inspection 1307194 of Give Legacy, March 10, 2026. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1307194
- Company Name: Give Legacy
- Inspection Date: 2026-03-10
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1305512 - 2026-02-27
- [FDA Inspection 1158848 - 2021-12-01](https://www.keypedia.com/records/fda_inspections/give-legacy/ed90b415-0c18-40cf-8c17-dcbca889005f)

## Related Officers

- [Amy Kim](https://www.keypedia.com/people/amy-kim/eee8b97a-b9d0-4709-96dc-70dbadd3a6a4)

Company: https://www.keypedia.com/companies/give-legacy/4dbaf2e3-e94c-45b0-a7fc-7686ed733f88

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
